Which of the following routes is used for administering Sufentanil (Sufenta)?

The choice of IV and sublingual tablet as the route for administering Sufentanil (Sufenta) is correct because Sufentanil is an opioid analgesic that can be rapidly absorbed into the bloodstream when given intravenously, providing quick pain relief, which is particularly important in acute settings such as surgery or in critical care. The sublingual tablet form offers a non-invasive method of administration, allowing for swift absorption through the mucous membranes in the mouth, achieving therapeutic levels of the drug without the need for intravenous access.

Other routes mentioned in the options are not typically associated with Sufentanil. While it can be administered intravenously, the buccal route is not a common recommendation for Sufentanil specifically. Rectal and oral options are less favored due to issues of variability in absorption and potential dosing challenges with opioids. The transdermal route, though used for other opioids, is not applicable for Sufentanil since it's not typically available or clinically preferred in that form. Inhalation as a route of delivery is also not standard for Sufentanil. Thus, the combination of IV and sublingual tablet forms is the most clinically relevant and supported by evidence for effective pain management with S